The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksMediumUpdated×7•Originally published 22 April 2026•Updated 23 April 2026•

1 min read

IBM Shares Slide 8% Despite Q1 Earnings Beat as Consulting Segment Weakens

Key Facts

1IBM reported Q1 revenue of $15.92 billion, exceeding analyst estimates of $15.61 billion.

2IBM shares fell more than 8% in after-hours trading due to weakness in the consulting segment.

about 1 month ago

Version History

1 additional source confirmed this story

Version 7about 1 month ago

What changed: Added details regarding the maintenance of full-year guidance and the specific timing of the share price drop in extended trading.

Version 6about 1 month ago

What changed: Added context regarding the steepest decline since February, analyst price-target cuts due to weak guidance, and the $220 technical support level.

Version 5about 1 month ago

What changed: Updated the story to include the revenue growth deceleration from 12.2% to 9% and the specific stock decline during pre-market trading.

Version 4about 1 month ago

What changed: Added specific EPS beat margin, dividend yield data, and consensus analyst price targets with rating.

Version 3about 1 month ago

What changed: Updated the story to include investor concerns regarding AI disruption and underwhelming software revenue as additional drivers for the stock decline.

Version 2about 1 month ago

What changed: Updated the story to confirm the beat on both top and bottom lines and included the NYSE ticker symbol.

Version 1about 1 month ago

What changed: Added CEO comments attributing cautious forward guidance to the war in Iran and global geopolitical uncertainty.

IBM reported robust Q1 2026 financial results, with revenue reaching $15.92 billion and surpassing projections. However, the stock recorded a sharp decline of over 8% during extended trading on April 22, 2026, as revenue growth slowed to 9%. The company maintained its full-year guidance, signaling a cautious stance that prompted multiple analysts to cut their price targets. While EPS of $1.91 beat expectations, concerns remain regarding the consulting segment's weakness and AI's disruptive impact. Traders are now closely watching the $220 level as a potential key technical support area. Despite the volatility, the consensus remains a 'Moderate Buy' with a price target of $298.81.